Hydrogen Cyanide Poisoning Workup
- Author: Lewis S Nelson, MD, FACEP, FAACT, FACMT; Chief Editor: Robert G Darling, MD, FACEP more...
Approach Considerations
Cyanide toxicity is characterized by a normal arterial oxygen tension and an abnormally high venous oxygen tension, resulting in a decreased arteriovenous oxygen difference (A-VO2). Also characteristic are a high-anion-gap metabolic acidosis and an elevated lactate level.[4, 10] In patients clinically suspected of cyanide poisoning, a serum lactate concentration above 8 mmol/L is a sensitive marker of toxicity.[10]
Serum cyanide concentrations are generally not available in time to guide acute treatment but may be confirmatory. The preferred test is a red blood cell (RBC) cyanide concentration. With this method, mild toxicity is observed at concentrations of 0.5-1.0 μg/mL. Concentrations of 2.5 μg/mL and higher are associated with coma, seizures, and death.
Obtain carboxyhemoglobin levels to exclude carbon monoxide poisoning, especially in smoke inhalation victims. Obtain a methemoglobin level, especially in cyanotic patients and following treatment of cyanide poisoning with sodium nitrite.
On electrocardiography (ECG), nonspecific findings predominate. Sinus bradycardia, tachycardia, heart block, or myocardial ischemic patterns may be noted.
Armstrong J. Chemical warfare. RN. Apr 2002;65(4):32-9. [Medline].
Greenfield RA, Brown BR, Hutchins JB. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. Jun 2002;323(6):326-40. [Medline].
Rosenbloom M, Leikin JB, Vogel SN. Biological and chemical agents: a brief synopsis. Am J Ther. Jan-Feb 2002;9(1):5-14. [Medline].
Baskin SI, Brewer TG. Cyanide poisoning. In: Medical Aspects of Chemical and Biological Warfare. 1997:271-286.
Morocco AP. Cyanides. Crit Care Clin. Oct 2005;21(4):691-705, vi. [Medline].
Sidell FR, Patrick WC, Dashiell TR. Cyanide. In: Jane's Chem-Bio Handbook. 1998:79-88.
USACHPPM. Cyanide. In: USACHPPM Tech Guide 244: The Medical NBC Battlebook. 1999:V-36-37.
Burda AM, Sigg T. Pharmacy preparedness for incidents involving weapons of mass destruction. Am J Health Syst Pharm. Dec 1 2001;58(23):2274-84. [Medline].
Lynch EL, Thomas TL. Pediatric considerations in chemical exposures: are we prepared?. Pediatr Emerg Care. Mar 2004;20(3):198-208. [Medline].
Baud FJ, Borron SW, Megarbane B. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. Sep 2002;30(9):2044-50. [Medline].
Musshoff F, Schmidt P, Daldrup T. Cyanide fatalities: case studies of four suicides and one homicide. Am J Forensic Med Pathol. Dec 2002;23(4):315-20. [Medline].
Brennan RJ, Waeckerle JF, Sharp TW. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med. Aug 1999;34(2):191-204. [Medline].
Department of the Army. Blood agents (Cyanogens). In: Field Manual 8-285: Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries. 1995:VI-1-2.
USAMRICD. Cyanide. In: Field Management of Chemical Casualties Handbook. 1996:37-40.
USAMRICD. Cyanide. In: Medical Management of Chemical Casualties Handbook. 1999:38-58.
Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med. Sep 1993;22(9):1413-8. [Medline].
Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. Jun 2007;25(5):551-8. [Medline].
Martin CO, Adams HP. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol. Jan 2003;60(1):21-5. [Medline].

